Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
World Neurosurgery|March 10, 2020
Prostate Cancer Brain Metastases: A Single-Institution ExperienceHriday P Bhambhvani, Daniel R Greenberg, Sandy Srinivas, et al.
JACC. Heart Failure|March 14, 2014
The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patientsPhilip S Hall, Lauren C Harshman, Sandy Srinivas, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Disparities in Adolescent and Young Adult Survival After Testicular Cancer Vary by Histologic Subtype: A Population-Based Study in California 1988-2010Mindy C DeRouen, Mahasin Mujahid, Sandy Srinivas, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment ConsiderationsBrian Dietrich, Arlene O Siefker-Radtke, Sandy Srinivas, et al.
European Urology|January 9, 2023
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin ToxicityGabriel E Molina, Ben Schwartz, Sandy Srinivas, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2013
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trialRichard Harrop, Franklin Chu, Nashat Gabrail, et al.
Targeted Oncology|November 18, 2022
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary TeamsNeal D Shore, Alicia K Morgans, Ghassan El-Haddad, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Application of pharmacoeconomics to formulary management in a health system settingAnn L Studdert, Cynthia L Gong, Sandy Srinivas, et al.
Nutrition Reviews|September 18, 2007
Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancerDavid Feldman, Aruna Krishnan, Jacqueline Moreno, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 23, 2017
Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinomaSandy Srinivas, Dara Stein, Dana Y Teltsch, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
World Neurosurgery|March 10, 2020
Prostate Cancer Brain Metastases: A Single-Institution ExperienceHriday P Bhambhvani, Daniel R Greenberg, Sandy Srinivas, et al.
JACC. Heart Failure|March 14, 2014
The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patientsPhilip S Hall, Lauren C Harshman, Sandy Srinivas, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Disparities in Adolescent and Young Adult Survival After Testicular Cancer Vary by Histologic Subtype: A Population-Based Study in California 1988-2010Mindy C DeRouen, Mahasin Mujahid, Sandy Srinivas, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment ConsiderationsBrian Dietrich, Arlene O Siefker-Radtke, Sandy Srinivas, et al.
European Urology|January 9, 2023
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin ToxicityGabriel E Molina, Ben Schwartz, Sandy Srinivas, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2013
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trialRichard Harrop, Franklin Chu, Nashat Gabrail, et al.
Targeted Oncology|November 18, 2022
Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary TeamsNeal D Shore, Alicia K Morgans, Ghassan El-Haddad, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Application of pharmacoeconomics to formulary management in a health system settingAnn L Studdert, Cynthia L Gong, Sandy Srinivas, et al.
Nutrition Reviews|September 18, 2007
Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancerDavid Feldman, Aruna Krishnan, Jacqueline Moreno, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 23, 2017
Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinomaSandy Srinivas, Dara Stein, Dana Y Teltsch, et al.
Pageof 16